Advertisement

A Glossary of Terms in Thrombocardiology

  • Patricia K. Hodgson
  • Robert A. Harrington
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 193)

Abstract

Abciximab Monoclonal antibody fragment inhibitor of the platelet glycoprotein IIb/IIIa receptor complex. Over a series of randomized clinical trials (EPIC, EPILOG, CAPTURE), it demonstrated its effectiveness in reducing ischemic complications of percutaneous coronary intervention. It is the first agent of its class approved for use in the setting of high-risk coronary angioplasty by the U.S. Food and Drug Administration.

Keywords

Percutaneous Coronary Intervention Acute Myocardial Infarction Thrombin Generation Thrombolytic Agent Tissue Factor Pathway Inhibitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • Patricia K. Hodgson
  • Robert A. Harrington

There are no affiliations available

Personalised recommendations